Italgel Launches Avvera Collagen Peptide June 12, 2026 With Bionos Biotech RCT in 67 Women: Faster Crow's-Feet Reduction at Day 28 vs Comparator Collagen at 2.5 g/Day
Italian producer Italgel launched avvera, a 'next-generation collagen for skin beauty,' on June 12, 2026 backed by a published double-blind parallel-group eight-week study conducted by Bionos Biotech S.L. in Spain. The randomized trial enrolled 67 healthy women aged 38-66 who received 2.5 g/day of either avvera or an established comparator collagen. Avvera showed greater reductions in crow's-feet wrinkle area and length at day 28, though between-group differences narrowed by day 56. Skin hydration improved 43.5% versus 42.9% for the active control at day 56. Italgel attributes the faster onset to its trademarked 'High-Dration System' production technology, which increases water storage in the skin while reducing transepidermal water loss via improved epidermal barrier function. The launch enters the cosmetic-peptide market alongside GELITA's CURADERM at Vitafoods Europe.